NVP-231 10mg 10mg | Purity Not Available
Adooq Bioscience
NVP-231 is a potent, specific, and reversible CerK inhibitor that competitively inhibits binding of ceramide to CerK.
More Information Supplier PageSearch Results
SKLB1002 50mg 50mg | Purity Not Available
Adooq Bioscience
SKLB1002 is a new potent VEGFR2 inhibitor, which could significantly inhibit HUVEC proliferation, migration, invasion, and tube formation.
More Information Supplier PageSKLB1002 5mg 5mg | Purity Not Available
Adooq Bioscience
SKLB1002 is a new potent VEGFR2 inhibitor, which could significantly inhibit HUVEC proliferation, migration, invasion, and tube formation.
More Information Supplier PageSKLB1002 25mg 25mg | Purity Not Available
Adooq Bioscience
SKLB1002 is a new potent VEGFR2 inhibitor, which could significantly inhibit HUVEC proliferation, migration, invasion, and tube formation.
More Information Supplier PageSKLB1002 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
SKLB1002 is a new potent VEGFR2 inhibitor, which could significantly inhibit HUVEC proliferation, migration, invasion, and tube formation.
More Information Supplier PageSKLB1002 10mg 10mg | Purity Not Available
Adooq Bioscience
SKLB1002 is a new potent VEGFR2 inhibitor, which could significantly inhibit HUVEC proliferation, migration, invasion, and tube formation.
More Information Supplier PageCNX-774 50mg 50mg | Purity Not Available
Adooq Bioscience
LGX 818 5mg 5mg | Purity Not Available
Adooq Bioscience
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageLGX 818 25mg 25mg | Purity Not Available
Adooq Bioscience
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageLGX 818 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
More Information Supplier Page